Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05054036 · ClinicalTrials.gov registry record · Phase 4

MoviPrep® Versus GoLYTELY® Bowel Preparation in Hospitalized Patients Undergoing Colonoscopy

A Phase 4 study, sponsored by Yale University.

Completed
Registry status
Phase 4
Development phase
520
Enrollment target

NCT05054036 is a Phase 4 study that has completed, run by Yale University. The registered enrollment target is 520 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05054036, a Phase 4 study, has completed, sponsored by Yale University.

COMPLETED
Registry status
Phase 4
Development phase
520 participants
Enrollment target

Study Summary

Adequate bowel cleansing is a critical component in the care of hospitalized patients undergoing colonoscopy. However, inpatient status is a well-established risk factor for inadequate bowel preparation. However, few strategies have been rigorously shown to reduce the risk of inadequate bowel preparation. Moreover, inadequate bowel preparation is frequently related to the poor tolerability of high volumes of bowel preparation in the medically complex and comorbid hospitalized population. Low volume bowel preparations have been developed that have been shown to be noninferior compared to high volume bowel preparation with regards to adequacy of bowel preparation but with improved tolerability. However, the use of low volume bowel preparations for colonoscopies have largely been evaluated in the outpatient setting. In this study, we plan to compare rates of adequate bowel preparation and tolerability of a low volume bowel preparation, MoviPrep, compared to standard high volume bowel preparation, GoLYTELY, in hospitalized patients undergoing colonoscopy. This study promises to highlight low volume bowel preparation as a viable and better tolerated alternative to high volume bowel preparation in hospitalized patients which may ultimately decrease delays in inpatient endoscopy as well as hospital length of stay.

Interventions

  • DRUG Golytely
  • DRUG MoviPrep

Trial Details

FieldValue
Enrollment Target 520 participants
Start Date 2022-01-12
Est. Completion 2024-07-01
Phase Phase 4

Sponsor

Yale University

1,492 total trials

What the Registry Record Tells You About NCT05054036

The ClinicalTrials.gov registry entry for NCT05054036 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 520 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Golytely is the first listed.

NCT05054036 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05054036 about?

NCT05054036 is a clinical study titled "MoviPrep® Versus GoLYTELY® Bowel Preparation in Hospitalized Patients Undergoing Colonoscopy". Adequate bowel cleansing is a critical component in the care of hospitalized patients undergoing colonoscopy. However, inpatient status is a well-established risk factor for inadequate bowel preparation. However, few strategies have been rigorously shown to reduce the risk of inadequate bowel prepar...

What is the current status of trial NCT05054036?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 520 participants. The study started on 2022-01-12. Estimated completion is 2024-07-01.

What interventions are being tested in trial NCT05054036?

The interventions under investigation include: Golytely (DRUG), MoviPrep (DRUG).

Who is sponsoring clinical trial NCT05054036?

This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.